During the past decade, Edwards Comprehensive Cancer Center conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 67 clinical trials were completed, i.e. on average, 104.7% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 38 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Edwards Comprehensive Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 54 trials, followed by "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "Children's Oncology Group" with 15 trials sponsored and "Bristol-Myers Squibb" with 15 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Edwards Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Edwards Comprehensive Cancer Center" are "Breast Cancer" (11 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Edwards Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "Edwards Comprehensive Cancer Center" are "Drug" (110 trials), "Other" (79 trials), "Biological" (48 trials), "Procedure" (28 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (33 trials), "Paclitaxel" (21 trials), "Carboplatin" (20 trials) and "Nivolumab" (15 trials). Other intervention names were less common.

The vast majority of trials in "Edwards Comprehensive Cancer Center" are 104 trials for "All" genders, 27 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Edwards Comprehensive Cancer Center". undefined are not yet recruiting, 22 are recruiting, 59 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Edwards Comprehensive Cancer Center, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Edwards Comprehensive Cancer Center, 3 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".